NCT00525096View on ClinicalTrials.gov

Exemestane + Celecoxib vs Exemestane + Placebo in Metastatic Breast Cancer

PHASE3CompletedINTERVENTIONAL
Enrollment

157

Participants

Timeline

Start Date

July 31, 2003

Primary Completion Date

December 31, 2004

Study Completion Date

December 31, 2004

Conditions
Metastatic Breast Cancer
Interventions
DRUG

placebo

2 tablets twice a day per os

DRUG

Celecoxib

2\*200 mg tablets twice a day per os

DRUG

Exemestane

Exemestane 25 mg per day per os

All Listed Sponsors
lead

ARCAGY/ GINECO GROUP

OTHER

NCT00525096 - Exemestane + Celecoxib vs Exemestane + Placebo in Metastatic Breast Cancer | Biotech Hunter | Biotech Hunter